A total of @ patients ( @ % ) receiving LCZ@ and @ patients ( @ % ) receiving enalapril died ( hazard ratio for death from any cause , @ ; @ % CI , @ to @ ; P < @ ) ; of these patients , @ ( @ % ) and @ ( @ % ) , respectively , died from cardiovascular causes ( hazard ratio , @ ; @ % CI , @ to @ ; P < @ ) .